Improvement in the signs and symptoms of dry eye disease with dobesilate eye drops

Pedro Cuevas; Luis Antonio Outeiriño; Carlos Azanza; Javier Angulo; Guillermo Giménez-Gallego

Your Location：

Home >

Browse articles >

Improvement in the signs and symptoms of dry eye disease with dobesilate eye drops

CASE REPORT | Updated：2026-03-12

- Improvement in the signs and symptoms of dry eye disease with dobesilate eye drops
- Military Medical Research Vol. 3, Issue 1, Pages: 51-55(2016)
- Affiliations：
  
  1.Facultad de Medicina, Universidad Alfonso X, Madrid, Spain
  2.Departamento de Oftalmología, Hospital de Día Pío XII, Madrid, Spain
  3.Servicio de Histología. Departamento de Investigación, IRYCIS; Hospital Universitario Ramón y Cajal, Madrid, Spain
  4.Departamento de Estructura y Función de Proteínas, Centro de Investigaciones Biológicas. CSIC, Madrid, Spain
- Author bio：
  
  *: pedro.cuevas44@gmail.com
- Funds：
- DOI：
  CLC：
- Published：2016-03
- Accepted：
Scan QR Code
Pedro Cuevas, Luis Antonio Outeiriño, Carlos Azanza, et al. Improvement in the signs and symptoms of dry eye disease with dobesilate eye drops[J]. Military Medical Research, 2016, 3(1): 51-55.
DOI：

Pedro Cuevas, Luis Antonio Outeiriño, Carlos Azanza, et al. Improvement in the signs and symptoms of dry eye disease with dobesilate eye drops[J]. Military Medical Research, 2016, 3(1): 51-55. DOI：

摘要

Abstract

Background:

Dry eye is a multifactor disease of the tear film and ocular surface that substantially affects quality of life.

Case presentation:

Dobesilate administered as eye drops was well tolerated and effective in treating both the objective signs and subjective symptoms of dry eye disease in this 2-week study.

Conclusion:

To the best of our knowledge

this is the first clinical report of using dobesilate in eye drops. Dobesilate may provide a novel approach to treating drying diseases of the eye.

关键词

Keywords

references

No authors listed . The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) . Ocul Surf . 2007 ; 5 : 75 - 92 .

Stern ME , Pflugfelder SC . Inflammation in dry eye . Ocul Surf . 2004 ; 2 : 124 - 30 .

Hessen M , Akpek EK . Dry eye: an inflammatory ocular disease . J Ophthalmic Vis Res . 2014 ; 9 : 240 - 50 .

Wei Y , Asbell PA . The core mechanism of dry eye disease is inflammation . Eye Contact Lens . 2014 ; 40 : 248 - 56 .

Niu L , Zhang S , Wu J , Chen L , Wang Y . Upregulation of NLRP3 inflammasome in the tears and ocular surface of dry eye patients . PLoS One . 2015 ; 10 : e0126277 .

Piller NB . Assessment of the anti-inflammatory action of calcium dobesilate. Effect on macrophages attaching to subcutaneously implanted coverslips in guinea pigs . Arzneimittelforschung . 1990 ; 40 : 698 - 700 .

Cuevas P , Angulo J , Giménez-Gallego G . Long-term effectiveness of dobesilate in the treatment of papulopustular rosacea . BMJ Case Rep . 2011 . doi: 10.1136/bcr.08.2011.4579 http://doi.org/10.1136/bcr.08.2011.4579 .

Cuevas P , Angulo J , Giménez-Gallego G . Topical treatment of contact dermatitis by pine processionary caterpillar . BMJ Case Rep . 2011 . doi: 10.1136/bcr.06.2011.4351 http://doi.org/10.1136/bcr.06.2011.4351 .

Angulo J , Cuevas P , Cuevas B , El Youssef M , Fernández A , Martínez-Salamanca E , et al . Diacetyloxyl derivatization of the fibroblast growth factor inhibitor dobesilate enhances its anti-inflammatory, anti-angiogenic and anti-tumoral activities . J Transl Med . 2015 ; 13 : 48 .

Abetz L , Rajagopalan K , Mertzanis P , Begley C , Barnes R , Chalmers R . Impact of dry eye on everyday Life (IDEEL) study group. Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients . Health Qual Life Outcomes . 2011 ; 9 : 111 .

No authors listed . Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007) . Ocul Surf . 2007 ; 5 : 163 - 78 .

Miljanović B , Dana R , Sullivan DA , Schaumberg DA . Impact of dry eye syndrome on vision-related quality of life . Am J Ophthalmol . 2007 ; 143 : 409 - 15 .

Lin PY , Tsai SY , Cheng CY , Liu JH , Chou P , Hsu WM . Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study . Ophthalmology . 2003 ; 110 : 1096 - 101 .

Schaumberg DA , Sullivan DA , Buring JE , Dana MR . Prevalence of dry eye syndrome among US women . Am J Ophthalmol . 2003 ; 136 : 318 - 26 .

Reddy P , Grad O , Rajagopalan K . The economic burden of dry eye: a conceptual framework and preliminary assessment . Cornea . 2004 ; 23 : 751 - 61 .

Stern ME , Beuerman RW , Fox RI , Gao J , Mircheff AK , Pflugfelder SC . The pathology of dry eye: the interaction between the ocular surface and lacrimal glands . Cornea . 1998 ; 17 : 584 - 9 .

Stevenson W , Chauhan SK , Dana R . Dry eye disease: an immune-mediated ocular surface disorder . Arch Ophthalmol . 2012 ; 130 : 90 - 100 .

Gayton JL . Etiology, prevalence, and treatment of dry eye disease . Clin Ophthalmol . 2009 ; 3 : 405 - 12 .

Stevenson D , Tauber J , Reis BL . Efficacy and safety of cyclosporin a ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The cyclosporin a phase 2 study group . Ophthalmology . 2000 ; 107 : 967 - 74 .

Marsh P , Pflugfelder SC . Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome . Ophthalmology . 1999 ; 106 : 811 - 6 .

Avunduk AM , Avunduk MC , Varnell ED , Kaufman HE . The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study . Am J Ophthalmol . 2003 ; 136 : 593 - 602 .

Cordero-Coma M , Anzaar F , Sobrin L , Foster CS . Systemic immunomodulatory therapy in severe dry eye secondary to inflammation . Ocul Immunol Inflamm . 2007 ; 15 : 99 - 104 .

Seal DV , Wright P , Ficker L , Hagan K , Troski M , Menday P . Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea . Br J Ophthalmol . 1995 ; 79 : 42 - 5 .

Stern ME , Gao J , Schwalb TA , Ngo M , Tieu DD , Chan CC , et al . Conjunctival T-cell subpopulations in Sjögren’s and non-Sjögren’s patients with dry eye . Invest Ophthalmol Vis Sci . 2002 ; 43 : 2609 - 14 .

Goyal S , Chauhan SK , El Annan J , Nallasamy N , Zhang Q , Dana R . Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity? Arch Ophthalmol . 2010 ; 128 : 819 - 24 .

oyal S , Chauhan SK , Dana R . Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease . Arch Ophthalmol . 2012 ; 130 : 84 - 9 .

Hajrasouliha AR , Sadrai Z , Chauhan SK , Dana R . b-FGF induces corneal blood and lymphatic vessel growth in a spatially distinct pattern . Cornea . 2012 ; 31 : 804 - 9 .

Allain H , Ramelet AA , Polard E , Bentué-Ferrer D . Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids . Drug Saf . 2004 ; 27 : 649 - 60 .

Fernández IS , Cuevas P , Angulo J , López-Navajas P , Canales-Mayordomo A , Lozano RM , et al . Gentisic acid, a compound associated with plant defence and a metabolite of aspirin, heads a new class of in vivo FGF inhibitor . J Biol Chem . 2010 ; 285 : 1714 - 29 .

Andrés G , Leali D , Mitola S , Coltrini D , Camozzi M , Corsini M , et al . A pro-inflammatory signature mediates FGF2-induced angiogenesis . J Cell Mol Med . 2009 ; 13 : 2083 - 108 .

Presta Y , Andrés G , Leali D , Dell’Era P , Ronca R . Inflammatory cells and chemokines sustain FGF2-induced angiogenesis . Eur Cytokine Netw . 2009 ; 20 : 39 - 50 .

Jonca F , Ortega N , Gleizes PE , Bertrand N , Plouet J . Cell release of bioactive fibroblast growth factor 2 by exon 6 encoded sequence of vascular endothelial growth factor . J Biol Chem . 1997 ; 272 : 24203 - 9 .

Mandriota SJ , Pepper MS . Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor . J Cell Sci . 1997 ; 110 : 2293 - 302 .

Angulo J , Peiró C , Romacho T , Fernández A , Cuevas B , González-Corrochano R , et al . Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial proliferation, arterial relaxation, vascular permeability and angiogenesis by dobesilate . Eur J Pharmacol. 2011 ; 667 : 153-9 .

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

EPAS1 and VEGFA gene variants are related to the symptoms of acute mountain sickness in Chinese Han population: a cross-sectional study

Study of the expression and transfer of VEGF in salivary glands and its saliva content in rats

Expression of VEGF, b-FGF, and their receptors after injection of VEGF on ischemic heart muscle

Relationship between dynamic contrast-enhanced MRI parameters and angiogenesis in peripheral pulmonary adenocarcinoma

Dynamic contrast-enhanced magnetic resonance perfusion weighted imaging in astrocytomas: correlation with histopathology and immunohistochemistry

Related Author

Chen Zhang

Lan Huang

Zhi-Nian Guo

Wen-Xu Pan

Fang-Zheng-Yuan Yuan

Jing-Bin Ke

Lai-Ping Zhang

Xu-Bin Gao

Related Institution

Institute of Cardiovascular Diseases, Department of Cardiology, Xinqiao Hospital, Army Medical University

Fujian Provincial Hospital Fuzhou

Second Military Medical University

Changhai Hospital

⁰